Eve simplifies the CCHD screening process, per an established protocol1, by providing visual instructions, animations, an automatic synchronization algorithm, and a detailed, easy-to-interpret display of screening results
Animations provide visual guidance to assist clinicians through the screening process
An automatic synchronization algorithm, with an easy-to-interpret results screen, may reduce calculation errors
Settings allow clinicians to incorporate perfusion index (Pi) measurement, which may increase sensitivity to detection of CCHD2
EMR integration via Masimo Patient SafetyNet™* or Iris Gateway™ facilitates workflow and may help reduce reporting errors
Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, Kelm K, Pearson GD, Glidewell J, Grosse SD, Howell, RR. Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics. 2011 Oct; 128(5):1259-67.
de-Wahl Granelli A et al. BMJ. 2009;338:a3037.
Zhao et al. Lancet. 2014 Aug 30;384(9945):747-54.
* The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.
Eve has obtained CE Marking. Not available in the U.S. Rad-97 with Eve is not licensed for sale in Canada.
For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.
© 2019 Masimo. All Rights Reserved.